Skip to content

Effects of Variations in Caffeinated Beverages on Well-being

A Randomized, Double-Blind, Parallel Trial to Assess Subjective and Physiological Responses to Consumption of Caffeinated Beverages in Healthy Adults With a Caffeine Routine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07404254
Enrollment
75
Registered
2026-02-11
Start date
2026-01-05
Completion date
2026-03-31
Last updated
2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Caffeine, Beverage Intake

Keywords

caffeine beverages in health and well-being

Brief summary

This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverage variations in generally healthy adults.

Detailed description

This will evaluate post-beverage subjective caffeine responses using visual analog scale questionnaires, mood, quality of life, and physiological responses to ingredient variations in caffeine beverages.

Interventions

OTHERCaffeinated, low sugar beverage

Participants will consume a caffeinated beverage with variations in sweetener and caffeine content.

OTHERCaffeinated beverage

Participants will consume a caffeinated beverage with variations in sweetener and caffeine content.

Participants will consume a caffeinated beverage with the control level of sweetener and caffeine content.

Sponsors

GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.
Lead SponsorINDUSTRY
Nlumn LLC
CollaboratorUNKNOWN
Alethios, Inc.
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

This interventional trial focuses on evaluating the effects of the intervention on health and well-being.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

1. Males or females, ≥18 to ≤55 years of age 2. BMI ≥18.5 and \<35.0 kg/m2 3. Generally good health 4. Participant currently and consistently has a sweetened caffeine routine 5. Participant is willing to substitute their current caffeine routine for the test beverage daily 6. Participant has never consumed the test beverage or similar products 7. Participant currently owns a wearable and is willing to use and connect the wearable device 8. Willing to use personal smart phone, tablet, or personal computer with stable internet connection 9. Willing and able to comply with all study procedures 10. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study

Exclusion criteria

1. History or presence, on the basis of the health history, of clinically important condition or disease states 2. Is currently following, or planning to be on, a weight loss regimen 3. Weight loss or gain \>4.5 kg 4. History of gastrointestinal surgery for weight reducing purposes or gastrointestinal (GI) conditions 5. History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator. 6. History of unconventional sleep patterns (e.g., night shift) or diagnosed sleep disorder 7. Use of tobacco/nicotine products 8. Use of hemp/marijuana products 9. Unstable use of any prescription medication 10. Use of any medications(s) or dietary supplement(s), containing caffeine, or interacting with caffeine 11. Recent history of alcohol or substance abuse 12. Exposed to any non-registered drug product 13. Self-report of hypertension/high blood pressure without use of hypertensive medications 14. Any known allergy or intolerance to any ingredients contained in the study product 15. Any signs or symptoms of active infection of clinical relevance 16. History or presence of cancer, except for non-melanoma skin cancer 17. History of any major trauma or major surgical event 18. Female who is pregnant, planning to be pregnant during the study period, lactating 19. An employee, close relative of an employee, or participant who has a financial interest in Sponsor company or any other caffeine beverage company. 20. Any condition the Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol 21. A clinically significant medical condition that is affected by caffeine

Design outcomes

Primary

MeasureTime frameDescription
Subjective caffeine visual analog scalesDay 5Participants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.

Secondary

MeasureTime frameDescription
Subjective caffeine visual analog scalesUp to 5 hours after beverage consumptionParticipants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.
Subjective quality of life ratingsDay 5Participants will rate how they feel using a Likert scale from 0-5. Where higher score indicate higher frequency in that feeling.
Physiological response - SleepUp to 5 hours post-beverage consumption and after 5 days of daily beverage consumptionSleep time in hours will be collected on wearable-derived algorithms (Apple Health, Garmin, or Fitbit).
Physiological responses - ActivityUp to 5 hours post-beverage consumption and after 5 days of daily beverage consumptionActivity in step count will be collected on wearables (Apple Health, Garmin, or Fitbit) via accelerometry.

Countries

United States

Contacts

CONTACTVP Product Innovation, Guayaki Sustainable Rainforest Products
info@guayaki.com609-799-6067
CONTACTAlethios, Inc.
support@alethios.com650-206-8006
PRINCIPAL_INVESTIGATORKristin Nieman, PhD

Nlumn LLC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026